$SYBX
SYNLOGIC, INC. Stock $sybx

$sybx Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-K Financial Statement

#000152759917000004 Filed on March 15, 2017

Income Statement

Concept	2017 Q1	2016 Q4	2016 Q2
Revenue	$111.0K	$111.0K	$111.0K
YoY Change	0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.370M	$1.840M	$1.140M
YoY Change	11.27%	-25.2%	-4.2%
% of Gross Profit
Research & Development	$5.118M	$2.341M	$3.682M
YoY Change	13.15%	-63.21%	-18.16%
% of Gross Profit
Depreciation & Amortization	$5.000K	$200.0K	$26.00K
YoY Change	-73.68%	1900.0%	30.0%
% of Gross Profit
Operating Expenses	$7.485M	$6.970M	$5.082M
YoY Change	90.12%	-21.02%	-10.59%
Operating Profit	-$7.374M	-$6.859M	-$4.971M
YoY Change	92.73%
Interest Expense	$8.000K	$10.00K	-$90.00K
YoY Change	-90.0%	-75.0%
% of Operating Profit
Other Income/Expense, Net	$6.000K	$88.00K	$93.00K
YoY Change	-92.68%	144.44%
Pretax Income	-$7.370M	-$6.850M	-$2.230M
YoY Change	12.18%	-22.07%	-60.74%
Income Tax
% Of Pretax Income
Net Earnings	-$7.368M	-$6.848M	-$4.972M
YoY Change	92.48%	-22.08%	-12.53%
Net Earnings / Revenue	-6637.84%	-6169.37%	-4479.28%
Basic Earnings Per Share
Diluted Earnings Per Share	-$3.859M	-$2.473M	-$13.12M
COMMON SHARES
Basic Shares Outstanding	20.86M shares	20.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q1	2016 Q4	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$57.50M	$14.60M	$72.60M
YoY Change	-28.66%	-83.72%	74.52%
Cash & Equivalents	$17.12M	$14.59M	$30.80M
Short-Term Investments	$40.40M	$0.00	$41.80M
Other Short-Term Assets	$600.0K	$31.00K	$900.0K
YoY Change	-33.33%	-96.13%	200.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$58.15M	$16.06M	$73.50M
YoY Change	-28.74%	-82.26%	75.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$26.00K	$3.504M	$1.200M
YoY Change	-94.8%	834.4%	1100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.400M	$422.0K	$2.400M
YoY Change			2300.0%
Total Long-Term Assets	$2.459M	$3.976M	$3.700M
YoY Change	391.8%	960.27%	1133.33%
TOTAL ASSETS
Total Short-Term Assets	$58.15M	$16.06M	$73.50M
Total Long-Term Assets	$2.459M	$3.976M	$3.700M
Total Assets	$60.61M	$20.04M	$77.20M
YoY Change	-26.18%	-77.96%	82.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$371.0K	$988.0K	$1.500M
YoY Change	-69.08%	-73.2%	0.0%
Accrued Expenses	$4.500M	$2.296M	$2.200M
YoY Change	125.0%	9.33%	37.5%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$200.0K
YoY Change
Total Short-Term Liabilities	$4.857M	$4.186M	$3.700M
YoY Change	51.78%	-29.06%	19.35%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$200.0K	$0.00
YoY Change
Other Long-Term Liabilities		$2.200M
YoY Change
Total Long-Term Liabilities	$0.00	$2.350M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.857M	$4.186M	$3.700M
Total Long-Term Liabilities	$0.00	$2.350M	$0.00
Total Liabilities	$4.857M	$3.814M	$3.700M
YoY Change	51.78%	-35.37%	19.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.00K	-$31.25M
YoY Change		-59.17%
Common Stock	$163.5M	$163.1M
YoY Change		1.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$55.75M	$8.503M	$73.50M
YoY Change
Total Liabilities & Shareholders Equity	$60.61M	$20.04M	$77.20M
YoY Change	-26.18%	-77.96%	82.94%

Cashflow Statement

Concept	2017 Q1	2016 Q4	2016 Q2
OPERATING ACTIVITIES
Net Income	-$7.368M	-$6.848M	-$4.972M
YoY Change	92.48%	-22.08%	-12.53%
Depreciation, Depletion And Amortization	$5.000K	$200.0K	$26.00K
YoY Change	-73.68%	1900.0%	30.0%
Cash From Operating Activities	-$3.216M	-$6.580M	-$5.130M
YoY Change	-64.16%	-0.6%	10.32%
INVESTING ACTIVITIES
Capital Expenditures	$125.0K	-$90.00K	-$410.0K
YoY Change	-12.59%	50.0%	720.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$16.56M
YoY Change	-100.0%
Cash From Investing Activities	$3.880M	-$90.00K	-$16.96M
YoY Change	-113.92%	50.0%	33820.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$25.00K	-240.0K	10.00K
YoY Change		-100.4%	-99.84%
NET CHANGE
Cash From Operating Activities	-$3.216M	-6.580M	-5.130M
Cash From Investing Activities	$3.880M	-90.00K	-16.96M
Cash From Financing Activities	$25.00K	-240.0K	10.00K
Net Change In Cash	$689.0K	-6.910M	-22.08M
YoY Change	-101.87%	-112.79%	-1622.76%
FREE CASH FLOW
Cash From Operating Activities	-$3.216M	-$6.580M	-$5.130M
Capital Expenditures	$125.0K	-$90.00K	-$410.0K
Free Cash Flow	-$3.341M	-$6.490M	-$4.720M
YoY Change	-63.35%	-1.07%	2.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	103114000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	102000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	251000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1729000	USD
CY2016Q4	mirn	Accrued Liabilities Employee Related Liabilities And Taxes Payable Current AccruedLiabilitiesEmployeeRelatedLiabilitiesAndTaxesPayableCurrent	2400000	USD
CY2015	mirn	Adjustments To Additional Paid In Capital Accretion Of Convertible Preferred Stock AdjustmentsToAdditionalPaidInCapitalAccretionOfConvertiblePreferredStock	449000	USD
CY2015Q4	mirn	Aggregate Deferred Tax Assets Net Of Liabilities AggregateDeferredTaxAssetsNetOfLiabilities	22440000	USD
CY2016Q4	mirn	Aggregate Deferred Tax Assets Net Of Liabilities AggregateDeferredTaxAssetsNetOfLiabilities	31737000	USD
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001527599
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20856693	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2016Q3	dei	Entity Number Of Employees EntityNumberOfEmployees	36	employee
CY2016Q2	dei	Entity Public Float EntityPublicFloat	60500000	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	Mirna Therapeutics, Inc.
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015Q4	mirn	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	489000	USD
CY2016Q4	mirn	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	220000	USD
CY2015Q4	mirn	Accrued Liabilities Employee Related Liabilities And Taxes Payable Current AccruedLiabilitiesEmployeeRelatedLiabilitiesAndTaxesPayableCurrent	2214000	USD
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	mirn	Amortization Period Of Additional Improvement Allowance AmortizationPeriodOfAdditionalImprovementAllowance	P120M
CY2016Q4	mirn	Available For Sale Securities Continuous Unrealized Loss Position Amortized Cost AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAmortizedCost	15400000	USD
CY2015Q4	mirn	Available For Sale Securities Debt Maturities After One Year AvailableForSaleSecuritiesDebtMaturitiesAfterOneYear	0	USD
CY2016Q4	mirn	Available For Sale Securities Debt Maturities After One Year AvailableForSaleSecuritiesDebtMaturitiesAfterOneYear	0	USD
CY2016Q4	mirn	Cash And Cash Equivalents And Available For Sale Securities CashAndCashEquivalentsAndAvailableForSaleSecurities	60500000	USD
CY2016	mirn	Defined Contribution Plan Employee Eligibility Period Of Service DefinedContributionPlanEmployeeEligibilityPeriodOfService	P90D
CY2015	mirn	Dividends Series C And Series D Preferred Stock DividendsSeriesCAndSeriesDPreferredStock	3871000	USD
CY2014	mirn	Dividends Series C Preferred Stock DividendsSeriesCPreferredStock	2824000	USD
CY2016	mirn	Employee Retention Costs EmployeeRetentionCosts	100000	USD
CY2015	mirn	Fair Value Asset Liability Transfers Between Level1 Level2 And Level3 Amount FairValueAssetLiabilityTransfersBetweenLevel1Level2AndLevel3Amount	0	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	31000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2016	mirn	Fair Value Asset Liability Transfers Between Level1 Level2 And Level3 Amount FairValueAssetLiabilityTransfersBetweenLevel1Level2AndLevel3Amount	0	USD
CY2010Q3	mirn	Grant Awards Term GrantAwardsTerm	P3Y
CY2014	mirn	Increase Decrease In Grant Reimbursement And Other Receivables IncreaseDecreaseInGrantReimbursementAndOtherReceivables	-40000	USD
CY2015	mirn	Increase Decrease In Grant Reimbursement And Other Receivables IncreaseDecreaseInGrantReimbursementAndOtherReceivables	-119000	USD
CY2016	mirn	Increase Decrease In Grant Reimbursement And Other Receivables IncreaseDecreaseInGrantReimbursementAndOtherReceivables	160000	USD
CY2014	mirn	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	99000	USD
CY2015	mirn	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	650000	USD
CY2016	mirn	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-107000	USD
CY2016Q2	mirn	Lessee Leasing Arrangements Operating Leases Areaof Leased Property LesseeLeasingArrangementsOperatingLeasesAreaofLeasedProperty	23578	sqft
CY2016Q4	mirn	Number Of Draws On Additional Improvement Allowance NumberOfDrawsOnAdditionalImprovementAllowance	0	draw
CY2016	mirn	Number Of Geographic Segments NumberOfGeographicSegments	1	segment
CY2016Q4	mirn	Number Of Terms Extend Lease NumberOfTermsExtendLease	2	term
CY2016	mirn	Number Of Votes Per Common Stock NumberOfVotesPerCommonStock	1	vote
CY2016	mirn	Operating Lease Percentage Increase In Base Rent Expense OperatingLeasePercentageIncreaseInBaseRentExpense	0.03
CY2016	mirn	Operating Lease Rent Expense Base Yearly Rental OperatingLeaseRentExpenseBaseYearlyRental	600000	USD
CY2016Q4	mirn	Operating Leases Future Minimum Payments Due Year Five And Thereafter OperatingLeasesFutureMinimumPaymentsDueYearFiveAndThereafter	4565888	USD
CY2010Q3	mirn	Proceedsfrom Grant Awards ProceedsfromGrantAwards	10300000	USD
CY2016	mirn	Rent Free Term RentFreeTerm	P3M
CY2016	mirn	Severanceand Employee Retention Costs SeveranceandEmployeeRetentionCosts	1554000	USD
CY2014	mirn	Stock Issuance Expense StockIssuanceExpense	1920000	USD
CY2016	mirn	Tenant Improvement Allowance TenantImprovementAllowance	1900000	USD
CY2016	mirn	Tenant Improvement Allowance Addition TenantImprovementAllowanceAddition	1300000	USD
CY2014	mirn	Write Off Of Offering Costs WriteOffOfOfferingCosts	1920000	USD
CY2015	mirn	Write Off Of Offering Costs WriteOffOfOfferingCosts	0	USD
CY2016	mirn	Write Off Of Offering Costs WriteOffOfOfferingCosts	0	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3687000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	361000	USD
CY2014	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2015	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2016	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-260000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	437000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	259000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	330000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	161518000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	163126000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	408000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	985000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1592000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	408000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	985000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1592000	USD
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6100850	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9450949	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1905214	shares
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	44070000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	7700	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	44066000	USD
CY2015Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1053000	USD
CY2015Q4	us-gaap	Assets Assets	90917000	USD
CY2016Q4	us-gaap	Assets Assets	64166000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	90542000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	61380000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	44066000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	44100000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	-4000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	8000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23182000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9319000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89713000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16432000	USD
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20830555	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20841393	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20830555	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20841393	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18658000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29303000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26272000	USD
CY2014	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2015	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	100938000	USD
CY2016	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19562000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27518000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1207000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1367000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1147000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1717000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	260000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	597000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	264000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	538000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22440000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	31737000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	0	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	0	USD
CY2014	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	91000	USD
CY2015	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	117000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-5365000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	169000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	35000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	159000	USD
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-291.00
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-60.99
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-78.87
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-82.16
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-5.85
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.26
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1151000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	154000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2016Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	128000	USD
CY2016Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-128000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3369000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	877000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1185000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1556000	USD
CY2015Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2462000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6080000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2130000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2049000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1940000	USD
CY2016Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1999000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8118000	USD
CY2015	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2016	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5675000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	9002000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	9287000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5383000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8494000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8931000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	94000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	153000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	216000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	386000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	661000	USD
CY2015	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2016	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	165000	USD
CY2016	us-gaap	Lessee Leasing Arrangements Operating Leases Renewal Term LesseeLeasingArrangementsOperatingLeasesRenewalTerm	P60M
CY2016	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P123M
CY2015	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	USD
CY2016	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	USD
CY2014	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-17000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	5901000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	3814000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90917000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64166000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5901000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2761000	USD
CY2014	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-13863000	USD
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	80394000	USD
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-73280000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	209000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	101780000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	572000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	189000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2816000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3264000	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1165000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	524000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1801000	USD
CY2014	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-105000	USD
CY2015	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
CY2016	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	2432000	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	44000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	350000	USD
CY2014	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	4000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	16000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-102000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-251000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-48491000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13970000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-21135000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-24805000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-15834000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-4279000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-5684000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7785000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	652340	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-6231000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-8789000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-24983000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-6571000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-5638000	USD
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8890000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	633364	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	614855	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	137000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29303000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26268000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	15834000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	4279000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	5684000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	6239000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	8825000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	25027000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	6653000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	5731000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	5452000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	8782000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	26618000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6917376	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	450929	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-8694000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-26268000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18658000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5397000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7229000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8000	USD
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	36000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	82000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	93000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	87000	USD
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	88000	USD
CY2016	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	158000	USD
CY2014	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2015	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2016	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-4000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4000	USD
CY2016	us-gaap	Other Restructuring Costs OtherRestructuringCosts	1500000	USD
CY2016	us-gaap	Other Restructuring Costs OtherRestructuringCosts	1486000	USD
CY2016	us-gaap	Payments For Restructuring PaymentsForRestructuring	457000	USD
CY2014	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2015	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	829000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3402000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4499000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4683000	USD
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6363000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18947000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4523000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3682000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3384000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2341000	USD
CY2014	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2824000	USD
CY2015	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4320000	USD
CY2016	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	882000	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	60280000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
CY2015	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	41433000	USD
CY2016	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
CY2014	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	USD
CY2015	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	USD
CY2016	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	58784000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	209000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	67000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	354000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10545000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13930000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2432000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016Q1	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016Q4	us-gaap	Restructuring Charges RestructuringCharges	4442000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	3040000	USD
CY2014	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2015	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2016	us-gaap	Restructuring Costs RestructuringCosts	4442000	USD
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	2700000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	2662000	USD
CY2016	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	79000	USD
CY2015Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102791000	USD
CY2016	us-gaap	Severance Costs1 SeveranceCosts1	1500000	USD
CY2016	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2014	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2824000	USD
CY2015	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	3871000	USD
CY2016	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1600000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1609000	USD
CY2016Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	1100000	USD
CY2014	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	0	USD
CY2015	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	0	USD
CY2016	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	4442000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-76523000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	408000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	985000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	1592000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	100938000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7000	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	209000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	67000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-29914000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-47951000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	85016000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	60352000	USD
CY2015Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0667
CY2016	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	1400000	USD
CY2016	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	1402000	USD
CY2014	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2015	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	449000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	9300000	USD
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	64131	shares
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5010323	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20833963	shares
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of credit risk</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and short-term marketable securities. The Company holds these investments in U.S. treasury and agency securities and highly‑rated corporate debt securities, and limits the amounts of credit exposure to any one financial institution. These amounts at times may exceed federally insured limits. The Company has not experienced any credit losses in such accounts and does not believe it is exposed to any significant credit risk on these funds. The Company has no off‑balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</font></div></div>
CY2016	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impairment of long‑lived assets</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company periodically evaluates its long‑lived assets for potential impairment in accordance with ASC Topic 360, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Property, Plant and Equipment</font><font style="font-family:inherit;font-size:10pt;">. Potential impairment is assessed when there is evidence that events or changes in circumstances indicate that the carrying amount of an asset may not be recovered. Recoverability of these assets is assessed based on undiscounted expected future cash flows from the assets, considering a number of factors, including past operating results, budgets and economic projections, market trends and product development cycles. If impairments are identified, assets are written down to their estimated fair value.</font></div></div>
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of estimates</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the IPO on October 6, 2015, the Company utilized significant estimates and assumptions in determining the fair value of its common stock. The board of directors determined the estimated fair value of the Company’s common stock based on a number of objective and subjective factors, including external market conditions affecting the biotechnology industry sector and the prices at which the Company sold shares of convertible preferred stock, the superior rights and preferences of securities senior to its common stock at the time and the likelihood of achieving a liquidity event, such as an initial public offering or sale of the Company.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to its IPO, the Company utilized various valuation methodologies in accordance with the framework of the American Institute of Certified Public Accountants, or AICPA, Audit and Accounting Practice Aid Series: </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Valuation of Privately Held Company Equity Securities Issued as Compensation</font><font style="font-family:inherit;font-size:10pt;">, or the AICPA Practice Aid, to estimate the fair value of its common stock. The methodologies included the Option Pricing Method utilizing the Backsolve Method (a form of the market approach defined in the AICPA Practice Aid) and the Probability‑Weighted Expected Return Method based upon the probability of occurrence of certain future liquidity events such as an initial public offering or sale of the Company. Each valuation methodology includes estimates and assumptions that require the Company’s judgment. Significant changes to the key assumptions used in the valuations could result in different fair values of common stock at each valuation date.</font></div></div>

Files In Submission

Name	View Source	Status
0001527599-17-000004-index-headers.html	Edgar Link	pending
0001527599-17-000004-index.html	Edgar Link	pending
0001527599-17-000004.txt	Edgar Link	pending
0001527599-17-000004-xbrl.zip	Edgar Link	pending
exhibit1024cirvinseperatio.htm	Edgar Link	pending
exhibit1026aoneillofferlet.htm	Edgar Link	pending
exhibit1026boneillemployme.htm	Edgar Link	pending
exhibit231eyconsent.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mirn-20161231.xml	Edgar Link	completed
mirn-20161231.xsd	Edgar Link	pending
mirn-20161231_cal.xml	Edgar Link	unprocessable
mirn-20161231_def.xml	Edgar Link	unprocessable
mirn-20161231_lab.xml	Edgar Link	unprocessable
mirn-20161231_pre.xml	Edgar Link	unprocessable
mirn_12312016x10kdocument.htm	Edgar Link	pending
mirn_12312016x10kex311.htm	Edgar Link	pending
mirn_12312016x10kex312.htm	Edgar Link	pending
mirn_12312016x10kex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
stockperformancegraph2a01.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SYBX
SYNLOGIC, INC. Stock $sybx

2017 Q1 Form 10-K Financial Statement

#000152759917000004 Filed on March 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SYBX SYNLOGIC, INC. Stock $sybx

2017 Q1 Form 10-K Financial Statement

#000152759917000004 Filed on March 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SYBX
SYNLOGIC, INC. Stock $sybx